Skip to main content
Fig. 2 | Applied Network Science

Fig. 2

From: Multilayer network analysis of the drugs development cycle in the global pharmaceutical industry

Fig. 2

The number of drug pipelines for each status, and these fractions of type of licenser and licensee. We show the top four countries in Fig. 1a US, b JPN, c CHN and d GBR. “Own country” in the legend represents the number of drug pipelines discovered by each country. In contrast, “other country” represents the number of drug pipelines at certain statuses by each country, where a different country discovers them. Similarly, “own company” in the legend represents the number of drug pipelines discovered by each country’s own company. “Other company” represents the number of drug pipelines at certain status by each country, where the different company discovers them from these owners

Back to article page